All articles by Douglas Strassler
AWIR was formed to promote the science and practice of rheumatology, with a focus on the advancement and education of women in the field.
The giant cell arteritis treatment tocilizumab has been approved by the FDA.
Alendronate treatment was associated with a significantly lower risk for hip fracture among older patients.
In patients with osteoarthritis, corticosteroid injection was associated with significant hip pain reduction.
The efficacy of lower doses of MTX in patients with rheumatoid arthritis in combination with ADA was studied.
Patients receiving disease-modifying anti-rheumatic drugs (DMARDs) saw no positive dynamics of mental disorders.
Sirukumab, a human monoclonal antibody that selectively binds to the interleukin 6 cytokine with high affinity, can help reduce depressive symptoms in patients with rheumatoid arthritis.
When combined with ultrasound examination, ANG-2 can help lead to the appropriate therapy for JIA.
MOCA is more effective than the Mini-Mental State Examination at detecting cognitive dysfunction.
The majority of patients with systemic lupus erythematosus have poor quality of sleep.
Cumulative steroid dosage is a risk factor for the development of osteonecrosis.
The approval of Kevzara® was based on data from approximately 2900 adults with moderate to severe RA with an inadequate response to previous treatment regimens.
Methotrexate discontinuation enabled a better seasonal influenza vaccination response in patients with rheumatoid arthritis.
Hip fracture and risk of major osteoporotic fracture were associated with psychotropic medication use.